Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
Alessandra Insinga(European Institute of Oncology), Saverio Minucci(University of Milan)
Cited by 118
Related Papers
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
|Nature reviews. Cancer|2006|2.2k
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner
|Nature Communications|2014|84
Dual modulation of MCL-1 and mTOR determines the response to sunitinib
|Journal of Clinical Investigation|2016|57